关注
Ildiko Molnár
Ildiko Molnár
Endomed
在 endomed.hu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Beneficial effect of pentoxifylline on thyroid associated ophthalmopathy (TAO): a pilot study
CS Balazs, E Kiss, A Vamos, I Molnar, NR Farid
The Journal of Clinical Endocrinology & Metabolism 82 (6), 1999-2002, 1997
831997
High circulating IL-6 level in Graves' ophthalmopathy
I Molnár, C Balazs
Autoimmunity 25 (2), 91-96, 1997
761997
High prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency
I Molnár, I Bohaty, É Somogyiné-Vári
Menopause 21 (7), 749-752, 2014
722014
Effect of anti-thyroid peroxidase (TPO) antibodies on TPO activity measured by chemiluminescence assay
V Kaczur, G Vereb, I Molnar, G Krajczar, E Kiss, NR Farid, C Balazs
Clinical chemistry 43 (8), 1392-1396, 1997
661997
IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis
I Molnár, I Bohaty, É Somogyiné-Vári
Osteoporosis International 25, 783-786, 2014
562014
Prevalence of iodine deficiency and goitre during pregnancy in east Hungary
E Mezosi, I Molnar, A Jakab, E Balogh, Z Karanyi, Z Pakozdy, P Nagy, ...
European Journal of Endocrinology 143 (4), 479-483, 2000
542000
Inhibition of type 2, 5′-deiodinase by tumor necrosis factor alpha, interleukin-6 and interferon gamma in human thyroid tissue
I Molnár, C Balázs, G Szegedi, S Sipka
Immunology letters 80 (1), 3-7, 2002
352002
The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy
I Molnár
Autoimmunity 40 (1), 31-37, 2007
282007
Decreased nerve growth factor levels in hyperthyroid Graves’ ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases
I Molnár, Á Bokk
Cytokine 35 (3-4), 109-114, 2006
202006
Euthyroid sick syndrome and inhibitory effect of sera on the activity of thyroid 5'-deiodinase in systemic sclerosis
I Molnar, L Czirjak
Clinical and experimental rheumatology 18 (6), 719-724, 2000
202000
Iodine deficiency in cardiovascular diseases
I Molnar, M Magyari, L Stief
Orvosi hetilap 139 (35), 2071-2073, 1998
161998
Anti-thyroid antibodies and hypothyroidism in systemic sclerosis
I Molnár, C Balazs, E Szabó, L Czirjak
J Endocrinol Invest 15 (4), 311, 1992
151992
Interactions among thyroid hormone (FT4), chemokine (MCP-1) and neurotrophin (NGF-β) levels studied in Hungarian postmenopausal and obese women
I Molnár
Cytokine 127, 154948, 2020
142020
Immunomodulatory effect of pentoxifylline in Graves ophthalmopathy
C Balazs, E Kiss, A Vamos, I Molnar, NR Farid
Orvosi hetilap 138 (45), 2869-2874, 1997
131997
Detectable serum IgE levels in Graves' ophthalmopathy.
I Molnar, S Horvath, C Balazs
European Journal of Medical Research 1 (11), 543-546, 1996
131996
IgA autoantibodies against human eye muscle antigen detected by western blotting and immunohistochemical methods in Graves’ disease
I Molnar, V Kaczur, A Boros, G Krajczar, C Balázs
Journal of endocrinological investigation 18, 408-414, 1995
131995
Cardiovascular consequences of thyroid diseases, their prevalence and treatment, particularly in cases with subclinical hyper-and hypothyroidism
I Molnár
Orvosi Hetilap 146 (40), 2067-2072, 2005
112005
Anti-platelet antibodies against gpIIb/IIIa in systemic sclerosis.
L Czirjak, I Molnar, I Csipö, M Szabolcs, A Mihaly, G Szegedi
Clinical and experimental rheumatology 12 (5), 527-529, 1994
111994
The prevalence and characteristics of allergy in autoimmune thyroid diseases
I Molnár, E Kelemen, E Somogyiné-Vári
J Clin Cell Immunol 6 (2), 2-7, 2015
92015
Evaluation of thyroid function and anti-thyroid autoantibodies in systemic sclerosis.
I Molnár, C Balázs, E Szabó, L Czirják
Acta dermato-venereologica 72 (2), 112-114, 1992
91992
系统目前无法执行此操作,请稍后再试。
文章 1–20